Anti-HDV-IgM levels as a marker of disease activity and response to pegylated Interferon-? based therapy in hepatitis delta

Wranke, AnikaYurdaydin, CihanHeidrich, BenjaminErnst, StefanieKoch, ArminSerrano, Beatriz CalleCaruntu, Florin A.2024-04-242024-04-2420130270-91391527-3350https://hdl.handle.net/11468/2313164th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases -- NOV 01-05, 2013 -- Washington, DC[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keyword]Anti-HDV-IgM levels as a marker of disease activity and response to pegylated Interferon-? based therapy in hepatitis deltaAnti-HDV-IgM levels as a marker of disease activity and response to pegylated Interferon-? based therapy in hepatitis deltaConference Object58651A651AWOS:000330252203098Q1